FGF6
Fibroblast growth factor 6
Also known as: FGF6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10767
- Gene
- FGF6
- Ensembl
- ENSG00000111241
- Chromosome
- 12
- Canonical length
- 208 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene displayed oncogenic transforming activity when transfected into mammalian cells. The mouse homolog of this gene exhibits a restricted expression profile predominantly in the myogenic lineage, which suggested a role in muscle regeneration or differentiation. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
208 residues, UniProt reviewed canonical sequence.
>P10767|FGF6
1 MALGQKLFIT MSRGAGRLQG TLWALVFLGI LVGMVVPSPA GTRANNTLLD SRGWGTLLSR
61 SRAGLAGEIA GVNWESGYLV GIKRQRRLYC NVGIGFHLQV LPDGRISGTH EENPYSLLEI
121 STVERGVVSL FGVRSALFVA MNSKGRLYAT PSFQEECKFR ETLLPNNYNA YESDLYQGTY
181 IALSKYGRVK RGSKVSPIMT VTHFLPRILocalizationUniProt · AlphaFold · HPA
Whether an antibody against FGF6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 13 nTPM
- tongue: 8.9 nTPM
- esophagus: 0.5 nTPM
- salivary gland: 0.1 nTPM
- testis: 0.1 nTPM
- adipose tissue: 0 nTPM
Single-cell type
- myonuclei: 34 nCPM
- medullary thymic epithelial cells: 2.4 nCPM
- retinal horizontal cells: 2 nCPM
- early spermatids: 1.2 nCPM
- fibro-adipogenic progenitors: 0.8 nCPM
- late primary spermatocytes: 0.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 1.3 nTPM
- cerebral cortex: 1.1 nTPM
- hippocampal formation: 1 nTPM
- basal ganglia: 0.9 nTPM
- hypothalamus: 0.4 nTPM
- medulla oblongata: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cartilage condensation
- fibroblast growth factor receptor signaling pathway
- myoblast differentiation
- neurogenesis
- positive regulation of cell division
- positive regulation of cell population proliferation
- positive regulation of MAPK cascade
- regulation of cell migration
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FGF6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FGF6 as an antibody target. Whether an autoantibody or antibody against FGF6 could matter depends on whether native FGF6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FGF6 is annotated as secreted, so native FGF6 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label FGF6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...